Endoscope Reprocessing Market Report Scope & Overview:

The Endoscope Reprocessing Market was valued at USD 2.50 Billion in 2025 and is expected to reach USD 5.70 Billion by 2035, growing at a CAGR of 8.40% from 2026 to 2035.

The Endoscope Reprocessing Market is witnessing strong growth driven by factors such as growing numbers of gastrointestinal, urology, and pulmonary endoscopy procedures being carried out globally, growing awareness about Healthcare-Associated Infections (HAI) and stringent guidelines regarding infection control. Automated endoscope reprocessors, superior high-level disinfectants and endoscope tracking systems are contributing to increased efficiencies in reprocessing. Advanced reprocessing equipment is being installed by hospitals and ambulatory surgical centers for improved patient safety. In addition, growing incidences of minimally-invasive procedures, technological innovations in flexible endoscopes, and increased healthcare spending are fueling market growth further in the coming years.

According to the World Health Organization (WHO), hundreds of millions of patients are affected by healthcare-associated infections (HAIs) each year globally. In acute-care hospitals, approximately 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries acquire at least one HAI during their hospital stay, underscoring the critical importance of effective endoscope reprocessing practices in preventing infection transmission and ensuring patient safety.

Market Size and Forecast

• Market Size in 2026E: USD 2.71 Billion

• Market Size by 2035: USD 5.70 Billion

• CAGR: 8.40% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

To Get more information on Endoscope Reprocessing Market - Request Free Sample Report

Endoscope Reprocessing Market Trends

• Rising emphasis on infection prevention and control driving adoption of advanced endoscope reprocessing systems in healthcare facilities

• Growing implementation of automated endoscope reprocessors (AERs) to improve cleaning consistency, workflow efficiency, and regulatory compliance

• Increasing use of endoscope tracking and digital documentation systems to enhance traceability, quality assurance, and patient safety

• Expanding demand for high-level disinfectants, drying cabinets, and storage solutions supporting effective reprocessing and reduced contamination risks

• Continuous advancements in automated monitoring, validation technologies, and standardized reprocessing protocols improving operational efficiency and infection control outcomes

The U.S. Endoscope Reprocessing Market Outlook

The U.S. Endoscope Reprocessing Market was valued at approximately USD 0.86 Billion in 2025 and is expected to reach approximately USD 1.77 Billion by 2035, growing at a CAGR of approximately 7.51%.

The United States is the world's largest endoscope reprocessing market within the dominant North American region, driven by the highest volume of endoscopic procedures in any single national market, the most comprehensive regulatory framework governing endoscope reprocessing including FDA guidance documents, CDC guidelines, and AAMI standards whose compliance creates measurable demand for validated reprocessing equipment, and the progressive transition of endoscopy from hospital-based to ambulatory surgical centre settings whose expansion is creating new reprocessing infrastructure investment cycles.

According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 31 hospitalized patients in the United States has at least one healthcare-associated infection (HAI) on any given day, reinforcing the critical need for rigorous endoscope reprocessing practices to prevent cross-contamination and ensure patient safety.

Endoscope Reprocessing Market Segment Analysis

• By Product Type, High-Level Disinfectants & Test Strips segment dominated the Endoscope Reprocessing Market in 2025 with 31% share; Endoscope Tracking Systems segment is the fastest growing segment.

• By Application, Disinfection segment dominated the market in 2025 with 64% share; Sterilization segment is the fastest growing segment.

• By Endoscope Type, Flexible Endoscopes segment dominated the market in 2025 with 72% share; Robotic-Assisted Endoscopes segment is the fastest growing segment.

• By End User, Hospitals segment dominated the market in 2025 with 66% share; Ambulatory Surgical Centers segment is the fastest growing segment.

By Product Type, High-Level Disinfectants & Test Strips segment dominates the Market, Endoscope Tracking Systems segment expected to grow fastest

The High-Level Disinfectants & Test Strips segment dominated the Endoscope Reprocessing Market in 2025 owing to their critical contribution in the process of decontamination of reusable endoscopes. Products from this segment remove dangerous microorganisms and help maintain the functionality of the medical device, thus making their presence mandatory in the course of the procedure. The test strips make sure that the disinfectant's concentration is at the necessary level and contributes to regulatory compliance.

The Endoscope Tracking Systems segment is the fastest growing in the Endoscope Reprocessing Market owing to the rising need for traceability and improvement of workflow in order to increase infection control. Healthcare institutions install tracking system to control all stages of utilization of endoscope – from use to storage and maintenance. These solutions increase the compliance to the regulation and improve the patient safety by keeping all records of the process.

By Application, Disinfection segment dominates the Endoscope Reprocessing Market, Sterilization segment expected to grow fastest

The Disinfection segment dominated the Endoscope Reprocessing Market in 2025 because high-level disinfection remains the standard method for reprocessing of majority of the reusable endoscopes, especially flexible endoscopes, which are not able to withstand multiple high temperature sterilization cycles. This procedure ensures the complete killing of pathogens without affecting equipment efficiency and durability. Increase in the number of minimally invasive surgeries along with strict infection prevention practices results in growing demand for the advanced disinfection methods and makes the segment leading in the market.

The Sterilization segment is the fastest growing in the Endoscope Reprocessing Market due to the rise in the demand for enhanced infection prevention methods and more rigorous safety standards in the healthcare industry. In order to eliminate microbes at a greater extent than before, healthcare facilities are increasingly adopting low temperature sterilization technology for compatible endoscopes. The development of sterilization equipment along with growing focus on reducing the healthcare associated infections and advancement of endoscopic procedures is driving the growth of this segment.

By Endoscope Type, Flexible Endoscopes segment dominates the Endoscope Reprocessing Market, Robotic-Assisted Endoscopes segment expected to grow fastest

The Flexible Endoscopes segment dominated the Endoscope Reprocessing Market in 2025 because of their wide usage in minimally invasive diagnostic and therapeutic procedures like gastrointestinal, pulmonary, urology, among others. The complex design of their inner channels requires thorough cleaning and sterilization after each procedure. Increased number of procedures, expansion of the health care infrastructure, and increased use of minimally invasive techniques are some of the factors that have made the segment more dominant in the global market.

The Robotic-Assisted Endoscopes segment is the fastest growing in the Endoscope Reprocessing Market because of the increased use of robotic surgical procedures which necessitate the use of sophisticated tools. Advanced reprocessing services are needed in order to ensure that these instruments perform effectively and safely. Increased investments in robotic surgery technology, increased demand for minimally invasive procedures, and expansion of the health care infrastructure are some of the factors fueling market growth.

By End User, Hospitals segment dominates the Endoscope Reprocessing Market, Ambulatory Surgical Centers segment expected to grow fastest

The Hospitals segment dominated the Endoscope Reprocessing Market in 2025 owing to the large number of diagnostic and therapeutic endoscopic procedures conducted in various specialties. Hospitals need comprehensive reprocessing solutions for ensuring patient safety, regulatory requirements, and process efficiency. In addition, hospitals also have investments in advanced automated reprocessing equipment along with infection control solutions to prevent contamination hazards. Growing admissions and expansion in the endoscopy department continue to drive the dominance of the segment.

The Ambulatory Surgical Centers segment is the fastest growing in the Endoscope Reprocessing Market on account of the ongoing trend of outpatient and minimal invasive procedures. The requirement of an effective reprocessing solution that allows high turnover of patients with strict infection control guidelines makes the ambulatory centers a major market segment. Increasing healthcare cost optimization, development of portable reprocessing systems and patient demand for same day surgeries are some of the factors driving this market segment.

Regional Analysis

North America Endoscope Reprocessing Market Insights

North America dominated the global Endoscope Reprocessing market in 2025, holding approximately 40.85% of global revenues. The United States accounts for approximately 84.73% of regional revenue through the world's highest endoscopic procedure volume, the most comprehensive regulatory framework governing reprocessing compliance, and the domestic presence of STERIS, Advanced Sterilization Products, and Medivators whose AER and reprocessing consumable product lines serve the U.S. hospital and ASC endoscopy ecosystem.

The progressive expansion of colorectal cancer screening colonoscopy programmes following the U.S. Preventive Services Task Force's 2021 guidance recommending screening beginning at age 45 rather than 50 is expanding annual colonoscopy volume and proportionally growing the reprocessing demand that each procedure creates.

The American Cancer Society estimates that more than 15 million colonoscopies are performed annually in the United States alone, significantly driving the demand for endoscope reprocessing equipment, consumables, and high-level disinfection systems to support this high procedural volume and maintain infection control standards.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Endoscope Reprocessing Market Insights

Europe held approximately 22.84% of global Endoscope Reprocessing revenues in 2025. Germany accounts for approximately 24.73% of European revenues through its large and high-quality hospital system, the domestic headquarters of Getinge AB's European operations, and the German medical device market's emphasis on validated, certified reprocessing equipment that sustains above-average per-facility reprocessing investment.

The EU Medical Device Regulation's requirements for reprocessing procedure documentation and the European Society of Gastrointestinal Endoscopy guidelines whose evidence-based reprocessing standards are widely adopted across European endoscopy units collectively sustain high reprocessing investment standards. France, the United Kingdom, Italy, and the Netherlands each contribute meaningful European demand through their hospital-based endoscopy programmes.

According to the European Centre for Disease Prevention and Control (ECDC), approximately 4.3 million patients acquire healthcare-associated infections (HAIs) annually across the European Union and European Economic Area. The ECDC further estimates that nearly 90,000 patients die each year in Europe due to HAIs, highlighting the significant clinical burden associated with these infections.

Asia Pacific Endoscope Reprocessing Market Insights

Asia Pacific is the fastest-growing regional Endoscope Reprocessing market, projected to expand at a CAGR of approximately 10.76% through 2035. China accounts for approximately 38.47% of Asia Pacific revenues through its rapidly expanding healthcare infrastructure investment, growing endoscopy suite capacity at both public and private hospitals, and the progressive adoption of automated reprocessing systems as Chinese healthcare facilities modernise their infection control practices.

India is the fastest-growing national market with a CAGR of approximately 10.40% as hospital infrastructure investment accelerates and awareness of endoscope-associated infection risk motivates systematic reprocessing programme investment. Japan, South Korea, and Australia each contribute meaningful Asia Pacific demand through their advanced healthcare systems and high endoscopy procedure volumes.

According to the World Health Organization (WHO), the Asia-Pacific region performs tens of millions of endoscopic procedures annually, driven by expanding healthcare infrastructure and a rising prevalence of gastrointestinal diseases. In addition, Japan represents one of the largest endoscopy markets globally, with approximately 15 million gastrointestinal endoscopic procedures performed each year, reflecting its advanced screening programs and high procedural adoption rates.

MEA & Latin America Endoscope Reprocessing Market Insights

Middle East and Latin America represent growing Endoscope Reprocessing markets where healthcare infrastructure expansion is creating new endoscopy capacity whose reprocessing requirement is being met through both domestic procurement and imported AER and consumable products. The UAE leads MEA revenues at approximately 22.84% of the regional total through its advanced private hospital sector, the prevalence of gastrointestinal disease in the region's population, and the growing medical tourism infrastructure that requires international-standard infection control practices including validated endoscope reprocessing.

Brazil leads Latin American revenues at approximately 43.84% of the regional total through its large public and private hospital network, the Brazilian Health Surveillance Agency's infection control regulations, and the growing colonoscopy screening awareness in Brazil's urban population.

Market Dynamics

Growth Drivers: Rising endoscopy procedures and strict regulations are driving strong demand for endoscope reprocessing solutions globally.

The expanding clinical applications of endoscopy, encompassing gastrointestinal cancer screening, inflammatory bowel disease monitoring, therapeutic interventional procedures, pulmonary diagnostic bronchoscopy, and urological and gynaecological minimally invasive surgery, are collectively driving global endoscopic procedure volume growth whose incremental procedure count creates proportional reprocessing demand.

The American Cancer Society's colorectal cancer screening programme, whose expansion to age 45 recommendations and high-profile public health campaigns have increased colonoscopy scheduling volumes, is a U.S.-specific structural demand driver whose effect on AER utilisation rates at colonoscopy-heavy facilities directly determines reprocessing equipment procurement cycles. Regulatory tightening by FDA, ECRI Institute, and national health authority recommendations following documented endoscope-associated infection events creates compliance investment mandates whose procurement trigger is regulatory obligation rather than discretionary capital allocation.

Restraints: High costs of automated reprocessors and skilled staffing requirements limit adoption in resource-constrained healthcare settings.

Automated endoscope reprocessors at the dual-basin, high-throughput end of the product range carry capital costs of USD 50,000 to USD 150,000 per unit before installation, plumbing integration, and staff training expenses that collectively raise total implementation costs substantially beyond equipment purchase price. Small and medium-sized healthcare facilities whose procedure volumes do not generate the scope throughput that justifies high-end AER capital investment face genuine economic barriers to automated reprocessing adoption, sustaining manual high-level disinfection practices whose efficacy is less consistent than validated automated alternatives.

Healthcare facilities in lower-income countries and rural settings within emerging economies face additional barriers including unreliable water quality, inconsistent chemical supply chains, and shortage of trained reprocessing technicians whose combination creates significant gaps between reprocessing guideline requirements and practical implementation capability.

Opportunities: AI-enabled monitoring systems and growing ambulatory surgical centers create major growth opportunities for market expansion.

AI-powered reprocessing monitoring systems that continuously analyse AER cycle parameters, scope tracking data, and reprocessing staff workflow patterns to identify compliance deviations, contamination risk signals, and process improvement opportunities represent a value-added service layer that endoscope reprocessing equipment manufacturers can deploy to create recurring software and service revenue streams that complement capital equipment and consumable sales.

The ASC market's rapid growth, combining expanding procedure volume with specific product requirement characteristics including compact footprint, rapid cycle time, and workflow documentation compatible with ASC information system architectures, creates a differentiated product development opportunity whose commercial addressing requires purpose-designed AER configurations that are distinct from the hospital-oriented systems whose design assumptions the ASC market cannot fully accommodate.

Recent Developments:

• 2025: Olympus Corporation launched the ScopeLocker Air endoscope drying cabinet with HEPA-filtered airflow maintaining microbiological quality for up to 30 days post-reprocessing, integrated with endoscope tracking software for automatic storage duration recording meeting Joint Commission accreditation documentation standards.

• 2025: STERIS PLC launched the Amsco Evolution Endoscope Reprocessor, a high-throughput dual-basin AER with integrated RFID scope identification, automatic cycle record upload to hospital infection control software, and independent parallel basin processing enabling simultaneous cycle completion documentation for two flexible endoscopes.

• 2024: HOYA Corporation completed acquisition of the remaining shares of PLASMABIOTICS to become sole owner of the France-based medical reprocessing company whose PlasmaTYPHOON and AquaTYPHOON systems provide enhanced low-temperature plasma sterilization reprocessing cycles for flexible endoscopes incompatible with high-temperature steam sterilization methods.

Endoscope Reprocessing Market Key Players are:

• STERIS plc

• Olympus Corporation

• Getinge AB

• Ecolab Inc.

• Advanced Sterilization Products (ASP)

• Cantel Medical

• Wassenburg Medical

• Steelco S.p.A.

• Belimed AG

• Metrex Research LLC

• Shinva Medical Instrument Co., Ltd.

• ARC Healthcare Solutions

• HOYA Corporation (PENTAX Medical)

• Nanosonics Limited

• Tristel Plc

• Miele Group

• Custom Ultrasonics Inc.

• BES Healthcare Ltd

• Creo Medical

• Richard Wolf GmbH

Endoscope Reprocessing Market Report Scope: